ArticleAdvances in therapy2019

Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark.

Richard F Pollock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.